Resources and Workforce Development for the Regional Biocontainment Laboratories
Project Number1UC7AI180254-01
Contact PI/Project LeaderSTAATS, HERMAN F
Awardee OrganizationDUKE UNIVERSITY
Description
Abstract Text
ABSTRACT – Overall
Duke University is pleased to respond to RFA-IP-22-075 entitled “Limited Competition: Resources and
Workforce Development for the Regional Biocontainment Laboratories”. Duke is one of 12-NIH funded
Regional Biocontainment Laboratories (RBLs) in the country and has played an instrument role in the world
class translational research being conducted at the DHVI and others throughout Duke and the Research
Triangle region, by providing BSL-3 suites for virology, immunology, microbiology, and animal model services.
Support from this grant will strengthen the overall infrastructure, ongoing facility and equipment maintenance,
establish an enhanced BSL-3 safety and training program, and enhance access to and capabilities of the
existing RBL Research Support services that are located in the BSL-3 environment. The significance of this
grant is that it will allow the Duke RBL to better respond to emerging infectious diseases and play a leading
role in pandemic preparedness. Specific Aims for this proposal are 1) to maintain reliable and uninterrupted
facility functionality; 2) to ensure a safe, secure, and compliant work environment; and 3) provide a state-of-
the-art biocontainment research environment and related support services that enhance the NIAID Biodefense
Facilities Network. This grant will continue to allow Duke to be a crucial resource to a team of internal and
external investigators dedicated to studying and countering select agents and BSL-3/ABSL-3 infectious agents
of global importance.
Public Health Relevance Statement
NARRATIVE
The Duke Regional Biocontainment Laboratory was commissioned in 2007 as a part of a network of 12 RBLs
tasked with providing state-of-the-art facilities to aid in the response emerging pathogens and pandemic
preparedness. This grant will provide critical support of the RBL operational infrastructure, comprehensive
training program, and enhancement of Research Support services.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Animal Disease ModelsAnimal ModelAnimalsAreaBacteriologyBasic ScienceBiologicalCell SeparationCenters of Research ExcellenceCollaborationsCommunitiesContainmentCountryDedicationsDevelopmentEducationEmerging Communicable DiseasesEnsureEnvironmentEquipmentFee-for-Service PlansFeesFundingGrantHealthHomeHumanHuman ResourcesImageImaging technologyImmunologyIncomeInfectious AgentInfrastructureInstitutionLaboratoriesLaboratory ResearchMaintenanceMicrobiologyNational Institute of Allergy and Infectious DiseasePathologyPlantsPlayProceduresProtocols documentationReadinessResearchResearch PersonnelResearch SupportResource DevelopmentResourcesRiskRoleSafetyScientistSecureSecurityService delivery modelServicesSterilityStructureSystemToxinTrainingTraining ProgramsTraining and InfrastructureTranslational ResearchUnited States National Institutes of HealthUniversitiesUpdateVaccine DesignVaccinesWorkWorkforce Developmentanimal imagingbiodefensebiosafety level 3 facilityemerging pathogenglobal healthhands on instructionimprovedin vivoinstrumentmedical countermeasuremedical schoolsnew pandemicoperationpandemic preparednesspandemic responsepathogenpathogenic virusprofessional atmosphereprofessorprogramsresponsesquare footsynergismtheoriesvirology
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
044387793
UEI
TP7EK8DZV6N5
Project Start Date
18-August-2023
Project End Date
31-July-2028
Budget Start Date
18-August-2023
Budget End Date
31-July-2024
Project Funding Information for 2023
Total Funding
$2,883,009
Direct Costs
$1,861,540
Indirect Costs
$1,021,469
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Allergy and Infectious Diseases
$2,883,009
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1UC7AI180254-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1UC7AI180254-01
Patents
No Patents information available for 1UC7AI180254-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1UC7AI180254-01
Clinical Studies
No Clinical Studies information available for 1UC7AI180254-01
News and More
Related News Releases
No news release information available for 1UC7AI180254-01
History
No Historical information available for 1UC7AI180254-01
Similar Projects
No Similar Projects information available for 1UC7AI180254-01